Silence Therapeutics plc
Pharmaceutical company · London, England, United Kingdom · Nasdaq: SLN
Silence Therapeutics plc is a pharmaceutical company headquartered in London, England, United Kingdom. Its earliest recorded incorporation is in 1994. Its shares trade on Nasdaq under the ticker SLN. It has reported private securities offerings to the US SEC, most recently $45 million sold in a notice filed in 2021. It is registered with UK Companies House under company number 02992058.
Silence Therapeutics at a glance
What does Silence Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $45.5 million sold (2021).
Frequently asked questions about Silence Therapeutics
Where is Silence Therapeutics headquartered?
Silence Therapeutics plc is headquartered in London, England, United Kingdom.
What does Silence Therapeutics do?
Silence Therapeutics plc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Silence Therapeutics a public company?
Yes. Silence Therapeutics plc trades on Nasdaq under the ticker SLN.
When was Silence Therapeutics founded?
The earliest incorporation on record for Silence Therapeutics plc is in 1994, according to public company registers.
Similar companies
- Kiniksa Pharmaceuticals International, plcLondon, England, United Kingdom
- Verona Pharma plcLondon, England, United Kingdom
- Mereo BioPharma Group plcLondon, England, United Kingdom
- Tiziana Life Sciences LtdLondon, England, United Kingdom
- Biodexa Pharmaceuticals PlcCardiff, Wales, United Kingdom
- F-star Therapeutics, Inc.Cambridge, England, United Kingdom
- Astrazeneca plcCambridge, England, United Kingdom
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Contains public sector information licensed under the Open Government Licence v3.0 (UK Companies House).
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.